Speaker Profile

MBA, Chief Commercial Officer, OncoHost

Biography
Chris Dingman has over 25 years of experience in the healthcare industry. A top performing, proven sales leader with extensive expertise in oncology, molecular diagnostics, and the pharmaceutical industries, Chris has a successful track record of developing and launching laboratory developed tests by growing commercial and marketing capabilities. Over the past 15 months, he has helped build OncoHost's US commercial operations. He is committed to hiring top tier, successful teams who put patients and physicians first.


Talk
Biomarker-Driven Treatment Decisions for Immunotherapy in NSCLC
OncoHost's PROphet® platform combines bioinformatics, system biology, proteomic pattern recognition, and machine learning in a cancer patient's blood plasma to guide treatment decision-making. This presentation will review the development, validation, and clinical utility of the first test from the platform, PROphet® NSCLC.


Clinical Dx Showcase:
OncoHost

OncoHost is a technology company transforming the approach to precision medicine for improved patient outcomes. Its PROphet® platform guides decision-making in the choice of first-line PD-(L)1 inhibitor treatment regimens for cancer patients, analyzes resistance mechanisms, and suggests potential treatment combinations to overcome this resistance.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S2 - January 24 9.30 A.M.-1.45 P.M.,Showcase Track S2 - January 25 9.00 A.M.-4.15 P.M.,Showcase Track S2 - January 26 9.00 A.M.-2.45 P.M.


The PMWC 2024 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.

  • Clinical Dx/Oncology (including Liquid Biopsy)
  • Clinical Dx/Cardio Vascular
  • Clinical Dx/Neurodegenerative

×

Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by JUL. 18TH

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts


Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required